Cumberland Pharmaceuticals Inc.

8-K Other events Jul 13, 2026 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Director or officer change; Other events Jul 1, 2026 8-K Shareholder vote results Jun 25, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Shareholder vote results Apr 24, 2026 8-K Entered a material agreement; Regulation FD disclosure; Other events Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Mar 3, 2026 8-K Other events Feb 4, 2026 8-K Entered a material agreement; Took on a direct financial obligation Nov 24, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Other events Oct 21, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 5, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Shareholder vote results Apr 28, 2025 8-K Other events Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Mar 7, 2025 8-K Results of operations (earnings release) Mar 4, 2025 8-K Other events Feb 19, 2025 8-K Other events Feb 14, 2025 8-K Other events Feb 4, 2025 8-K Other events Dec 9, 2024 8-K Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Nov 6, 2024 8-K Other events Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 6, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Shareholder vote results Apr 29, 2024 8-K Other events Mar 20, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 5, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023